Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Calvo-Río, Vanesa
180  Ergebnisse:
Personensuche X
?
1

Intravenous immunoglobulin therapy in antineutrophil cytopl..:

Benavides-Villanueva, Fabricio ; Loricera, Javier ; Calvo-Río, Vanesa...
European Journal of Internal Medicine.  117 (2023)  - p. 78-84 , 2023
Link: https://doi.org/10.1016/..
 
?
2

ANCA detection with solid phase chemiluminescence assay: di..:

Renuncio-García, Mónica ; Calvo-Río, Vanesa ; Benavides-Villanueva, Fabricio...
Immunologic Research.  72 (2023)  1 - p. 128-133 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Uveitis in psoriatic arthritis: study of 406 patients in a ..:

De Vicente Delmás, Ana ; Sanchez-Bilbao, Lara ; Calvo-Río, Vanesa...
RMD Open.  9 (2023)  1 - p. e002781 , 2023
Link: https://doi.org/10.1136/..
 
?
4

Mucosal Immune Defence Gene Polymorphisms as Relevant Playe..:

Batista-Liz, Joao Carlos ; Calvo-Río, Vanesa ; Sebastián Mora-Gil, María...
International Journal of Molecular Sciences.  24 (2023)  17 - p. 13063 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Anti-TNF vs tocilizumab in refractory uveitic cystoid macul..:

Barroso-García, Nuria ; Atienza-Mateo, Belén ; Ferraz-Amaro, Iván...
Seminars in Arthritis and Rheumatism.  58 (2023)  - p. 152153 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Factors associated with atherosclerosis in radiographic and..:

Rueda-Gotor, Javier ; Ferraz-Amaro, Iván ; Genre, Fernanda...
Seminars in Arthritis and Rheumatism.  55 (2022)  - p. 152037 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Baricitinib in severe and refractory peripheral ulcerative ..:

Calvo-Río, Vanesa ; Sánchez-Bilbao, Lara ; Álvarez-Reguera, Carmen...
Therapeutic Advances in Musculoskeletal Disease.  14 (2022)  - p. 1759720X2211371 , 2022
Link: https://doi.org/10.1177/..
 
?
8

Long-term follow-up of certolizumab pegol in uveitis due to..:

Martín-Varillas, José Luis ; Sanchez-Bilbao, Lara ; Calvo-Río, Vanesa...
RMD Open.  8 (2022)  2 - p. e002693 , 2022
Link: https://doi.org/10.1136/..
 
?
9

Risk Factors for the Development of the Disease in Antiphos..:

Pablo, Rosalía Demetrio ; Cacho, Pedro Muñoz ; López-Hoyos, Marcos...
Clinical Reviews in Allergy & Immunology.  62 (2021)  2 - p. 354-362 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Biologic Therapy in Refractory Non-Multiple Sclerosis Optic..:

Herrero-Morant, Alba ; Álvarez-Reguera, Carmen ; Martín-Varillas, José L....
Journal of Clinical Medicine.  9 (2020)  8 - p. 2608 , 2020
Link: https://doi.org/10.3390/..
 
?
11

Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbito..:

Sánchez-Bilbao, Lara ; Martínez-López, David ; Revenga, Marcelino...
Journal of Clinical Medicine.  9 (2020)  9 - p. 2816 , 2020
Link: https://doi.org/10.3390/..
 
?
12

Biologic therapy in severe and refractory peripheral ulcera..:

Dominguez-Casas, Lucia C. ; Sánchez-Bilbao, Lara ; Calvo-Río, Vanesa...
Seminars in Arthritis and Rheumatism.  50 (2020)  4 - p. 608-615 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectio..:

Vegas-Revenga, Nuria ; Calvo-Río, Vanesa ; Mesquida, Marina...
American Journal of Ophthalmology.  200 (2019)  - p. 85-94 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Predictors of positive 18F-FDG PET/CT-scan for large vessel..:

Prieto-Peña, Diana ; Martínez-Rodríguez, Isabel ; Loricera, Javier...
Seminars in Arthritis and Rheumatism.  48 (2019)  4 - p. 720-727 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Anti-interleukin 6 receptor tocilizumab in refractory uveit..:

Atienza-Mateo, Belén ; Calvo-Río, Vanesa ; Beltrán, Emma...
Rheumatology.  57 (2018)  5 - p. 856-864 , 2018
Link: https://doi.org/10.1093/..
 
1-15